EVQLV Company
Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies
Technology:
Artificial Intelligence, Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical
Industry:
Early Drug Development
Headquarters:
New York, New York, United States
Founded Date:
2019-12-15
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
6
Total Funding:
360000
Last Funding Date:
2023-02-13
Last Funding Type:
Grant
Register and Claim Ownership